Literature DB >> 11892083

Lyme disease: an update.

A R Marques1.   

Abstract

Lyme disease is a multisystem illness caused by the spirochete Borrelia burgdorferi, and it is the most common vector-borne illness in the United States. Lyme disease is also endemic in Europe and Asia. There have been major advances in the field since the disease was first described, including the sequencing of the B. burgdorferi genome; an increase in understanding of the interactions among the spirochete, the tick, and the mammalian host; new and improved laboratory tests; and a vaccine for prevention of the disease. Still, the diagnosis of Lyme disease remains based on history and clinical findings, supplemented by careful use of laboratory tests, and requires that the physician be familiar with the disease's clinical manifestations and the shortcomings of the available diagnostic tests.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11892083     DOI: 10.1007/s11882-001-0063-x

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  72 in total

1.  Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL.

Authors:  F T Liang; E Aberer; M Cinco; L Gern; C M Hu; Y N Lobet; M Ruscio; P E Voet; V E Weynants; M T Philipp
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

2.  Influence of outer surface protein A antibody on Borrelia burgdorferi within feeding ticks.

Authors:  A M de Silva; N S Zeidner; Y Zhang; M C Dolan; J Piesman; E Fikrig
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia.

Authors:  F Strle; R B Nadelman; J Cimperman; J Nowakowski; R N Picken; I Schwartz; V Maraspin; M E Aguero-Rosenfeld; S Varde; S Lotric-Furlan; G P Wormser
Journal:  Ann Intern Med       Date:  1999-01-05       Impact factor: 25.391

4.  Borrelia burgdorferi enzyme-linked immunosorbent assay for discrimination of OspA vaccination from spirochete infection.

Authors:  Y Q Zhang; D Mathiesen; C P Kolbert; J Anderson; R T Schoen; E Fikrig; D H Persing
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

5.  Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis.

Authors:  J J Nocton; B J Bloom; B J Rutledge; D H Persing; E L Logigian; C H Schmid; A C Steere
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

6.  Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans.

Authors:  M E Aguero-Rosenfeld; J Nowakowski; S Bittker; D Cooper; R B Nadelman; G P Wormser
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

7.  Antibody response in white-footed mice (Peromyscus leucopus) experimentally infected with the Lyme disease spirochete (Borrelia burgdorferi).

Authors:  T G Schwan; K K Kime; M E Schrumpf; J E Coe; W J Simpson
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

8.  Comparison of peripheral and central biopsy sites for the isolation of Borrelia burgdorferi sensu lato from erythema migrans skin lesions.

Authors:  T Jurca; E Ruzić-Sabljić; S Lotric-Furlan; V Maraspin; J Cimperman; R N Picken; F Strle
Journal:  Clin Infect Dis       Date:  1998-09       Impact factor: 9.079

9.  Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis.

Authors:  M Karlsson; K Hovind-Hougen; B Svenungsson; G Stiernstedt
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

10.  Genetic variation of the Borrelia burgdorferi gene vlsE involves cassette-specific, segmental gene conversion.

Authors:  J R Zhang; S J Norris
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.